Claude V. Winder
- Co-authors
- Eldon M. JonesPaul BassLuciana ScottiRobert A. ScherrerD. H. KaumpMichael D. BeenAnthony J. GlazkoBeatriz Serrano
- Topics
- Cancer Treatment and Pharmacology (3 papers)Synthesis of β-Lactam Compounds (3 papers)Inflammatory mediators and NSAID effects (3 papers)
- Cited by
- PharmacologyToxicology
- Partner nations
- United States
In The Last Decade
Claude V. Winder
21 papers receiving 405 citations
Peers
Comparison fields: 5 of 93
- Pharmacology 214
- Pharmacology 111
- Molecular Biology 110
- Organic Chemistry 103
- Physiology 69
Countries citing papers authored by Claude V. Winder
This map shows the geographic impact of Claude V. Winder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude V. Winder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude V. Winder more than expected).
Fields of papers citing papers by Claude V. Winder
This network shows the impact of papers produced by Claude V. Winder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude V. Winder. The network helps show where Claude V. Winder may publish in the future.
Co-authorship network of co-authors of Claude V. Winder
This figure shows the co-authorship network connecting the top 25 collaborators of Claude V. Winder. A scholar is included among the top collaborators of Claude V. Winder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude V. Winder. Claude V. Winder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | Structure-activity relationships in a series of anti-inflammatory N-arylanthranilic acids. | 8 |
| 3 | 1 | |
| 4 | 25 | |
| 5 | 4 | |
| 6 | 84 | |
| 7 | 3 | |
| 8 | 78 | |
| 9 | 6 | |
| 10 | 12 | |
| 11 | 31 | |
| 12 | 33 | |
| 13 | 55 | |
| 14 | 67 | |
| 15 | 2 | |
| 16 | 21 | |
| 17 | 17 | |
| 18 | 23 | |
| 19 | A study of pharmacological influences on ultraviolet erythema in guinea pigs. | 47 |
| 20 | 7 |
About Claude V. Winder
Claude V. Winder is a scholar working on Pharmacology, Clinical Biochemistry and Pharmacology, having authored 21 papers that have together received 543 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Synthesis of β-Lactam Compounds (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Pharmacology (111 citations), Pharmacology (214 citations) and Toxicology (17 citations). Claude V. Winder has collaborated with scholars based in United States. Frequent co-authors include Eldon M. Jones, Paul Bass, Luciana Scotti, Robert A. Scherrer, D. H. Kaump, Michael D. Been, Anthony J. Glazko, Beatriz Serrano, D. J. Read and John Davoll. Their work appears in journals such as Nature, Gastroenterology and Journal of Applied Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.